Striascan

(ioflupane (123l))

Uses, side effects, dosage information & price range

CIS bio international

About this medicine

This medicinal product is for diagnostic use only. Striascan is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum: In adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic Parkinsons disease, multiple system atrophy and progressive supranuclear palsy. Striascan is unable to discriminate between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. In adult patients, to help differentiate probable dementia with Lewy bodies from Alzheimers disease. Striascan is unable to discriminate between dementia with Lewy bodies and Parkinsons disease dementia.

Common Brand Names for this Composition

The following popular commercial brand names contain ioflupane (123l) as their active ingredient composition:

Striascan

CIS bio international

MRPPrice on Request

DaTSCAN

GE Healthcare B.V.

MRPPrice on Request

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

DaTSCANComposition: ioflupane (123l)GE Healthcare B.V.

Price on RequestView Details →

Key Information

Salt / Composition

ioflupane (123l)